PATENT CLAIM ANALYSIS

Application Number: 16151730
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "298000"]

Abstract:
This invention relates to the use of low doses of (+)-α-dihydrotetrabenazine for the treatment of movement disorders, such as Tourette's syndrome.

Claim (Index 16):
A method according to  claim 14  wherein the movement disorder is Huntington's Disease.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15939826', '15939837', '12555695', '15116786', '14442996']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8358274964258351
- 35 USC 102 Novelty (BERT): 0.5408967181714676
- Combined Prediction Score: 0.8063344186003983
- Mean Citation Score: 432.914024
- Max Citation Score: 644.5441
- Similarity Product: 245.8382561742544

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test